Luana Teles de Sá Maia
Research Interests
Luana Teles de Sá Maia has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Cavalcante de Albuquerque
Hospital de Base Ary Pinheiro
1 shared publication - Andrezza Maria de Oliveira
Hospital de Base Ary Pinheiro
1 shared publication - Daniel Kucharski Frari
CENTRO UNIVERSITÁRIO SÃO LUCAS
1 shared publication - Ennely Mendonça Gutzeit
Hospital João Paulo II
1 shared publication - Iara Vaz Lopes
Centro Universitário Aparício Carvalho
1 shared publication - Luiz Carlos Ufei Hassegawa
Hospital de Base Ary Pinheiro
1 shared publication
Latest Publications
- Open Access
- 30 August 2022
- Published by e-Academica in E-Acadêmica
- Vol. 3 (3) , e2233295
Tratamento em terapia intensiva, de pacientes com hipertensão: Relato de três casos
The impact of clinical hypertension, however, is pointed out as a major predisposition to worsening, in with COVID-19 in this interaction still insufficiently investigated. The coronavirus disease 2019 (COVID-19) has become a worldwide responsible for a worldwide pandemic of deaths. Common hypertension has been identified as one of the comorbidities and risk factors for severity and adverse consequences. Recent investigations raise the question of hypertension a predictor of patients with COVID-19 independently of others such as chronic diseases, obesity, other cardiovascular diseases, kidney, liver and lung diseases. The purpose of this report was to provide a clinical view of hypertension in intensive care with or without the effect of blood pressure levels, the impact of previously known hypertension and the effect of antihypertensive therapy on severity and outcomes in patients with and without COVID-19.
- 30 August 2022
- Published by e-Academica in E-Acadêmica
- Vol. 3 (3) , e2233295
Open AccessTratamento em terapia intensiva, de pacientes com hipertensão: Relato de três casos
The impact of clinical hypertension, however, is pointed out as a major predisposition to worsening, in with COVID-19 in this interaction still insufficiently investigated. The coronavirus disease 2019 (COVID-19) has become a worldwide responsible for a worldwide pandemic of deaths. Common hypertension has been identified as one of the comorbidities and risk factors for severity and adverse consequences. Recent investigations raise the question of hypertension a predictor of patients with COVID-19 independently of others such as chronic diseases, obesity, other cardiovascular diseases, kidney, liver and lung diseases. The purpose of this report was to provide a clinical view of hypertension in intensive care with or without the effect of blood pressure levels, the impact of previously known hypertension and the effect of antihypertensive therapy on severity and outcomes in patients with and without COVID-19.